Ignite Creation Date:
2024-05-06 @ 7:23 AM
Last Modification Date:
2024-10-26 @ 11:47 AM
Study NCT ID:
NCT02523885
Status:
COMPLETED
Last Update Posted:
2016-02-26
First Post:
2015-08-13
Brief Title:
Use of Non Steroidal Antiinflammatory Drugs in Patients With Community Acquired Pneumonia
Sponsor:
Hôpital Louis Mourier
Organization:
Hôpital Louis Mourier
Study Overview
Official Title:
Descriptive Analysis of Non Steroidal Antiinflammatory Drugs Use in Patients Diagnosed With Community Acquired Pneumonia
Status:
COMPLETED
Status Verified Date:
2016-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
ALPAJ
Brief Summary:
To investigate exposure to nonsteroidal antiinflammatory drugs NSAIDs during outpatient management at the early stage of community-acquired pneumonia CAP requiring hospital consultation Non-interventional observational study
Detailed Description:
Recent data suggests that such exposure to NSAIDs is associated with delay in CAP diagnosis and antibiotic prescription that influence CAP presention and outcome The investigators working hypothesis is that NSAIDs use may mask initial symptoms and delay antimicrobial therapy thus predisposing to worse outcomes All patients presenting at one of the three following locations emergency department ICU or pneumology ward with a suspicion of community-acquired pneumonia will be screened for eligibility Exposure or not to NSAIDs will be investigated Clinical biological and radioloigcal features and outcome of CAP will be compared with respect to NSAIDs exposure
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None